Post
of 131,396
$CYDY News Article - FDA Resumes eIND Approval for Severe-to-Critical COVID-19 Patients Use of Vyrologix(TM) (leronlimab) Following Full Enrollment in CytoDyn's Phase 3 Trial https://marketwirenews.com/news-releases/fda-...02452.html
My Twitter: WhyteStocks